Cannabis News
Fact Checking CNN’s Claim That Some Cannabis Products Now Have 90% THC Levels
Sniping CNN’s Reefer Madness Article
One would think that in 2023, Reefer Madness articles would be essentially non-existent. However, here we are with CNN publishing some unscientific anti-reefer nonsense, most probably sponsored by their sugar daddies – Pfizer.
Nonetheless, it’s my duty as a cannabis activist to dismember the propaganda and show people just how insidious these media companies are. Even though no one really takes CNN seriously anymore.
Throughout this article, I’ll be breaking down specific parts of the original CNN article which can be found HERE in its entirety.
CNN:
Marijuana and other products containing THC, the plant’s main psychoactive ingredient, have grown more potent and more dangerous as legalization has made them more widely available. Although decades ago the THC content of weed was commonly less than 1.5%, some products on the market today are more than 90% THC.
The buzz of yesteryear has given way to something more alarming. Marijuana-related medical emergencies have landed hundreds of thousands of people in the hospital and millions are dealing with psychological disorders linked to cannabis use, according to federal research.
But regulators have failed to keep up.
Reginald:
Firstly, while there are some truths mixed within this opening statement, there are also plenty of falsehoods scattered about. For example, the statement that “Although decades ago the THC content of weed was commonly less than 1.5%, some products on the market today are more than 90% THC.”
This is inherently false. Most people did not smoke weed with 1.5% THC or less decades ago. There have always been the knowledge that “some cannabis strains are more potent”, and people knew this in the 1950s and 1960s. Cannabis has been around for thousands of years, and people have used it for its psychoactive properties.
In fact, the use and manipulation of the plant into its many forms have been intertwined with the fabric of our global society. Every culture at some point in time utilized cannabis as a medicine and for industrial purposes.
Therefore, the assumption that during the early 1900s up to the 1960s, there was no understanding of potency, selective breeding, etc – is ludicrous.
While it’s true that most weed available to the markets were either “ditch weed” which was low potency, or cannabis shipped from Mexico. Mexican weed does have a lower than average percentage of THC, however, you’d still see on average potency between 4.5% – 9%.
CNN:
Pot has changed profoundly since generations of Americans were first exposed to it.
Cannabis has been cultivated to deliver much higher doses of THC. In 1980, the THC content of confiscated marijuana was less than 1.5%. Today many varieties of cannabis flower — plant matter that can be smoked in a joint — are listed as more than 30% THC.
At one California dispensary, the menu recently included a strain posted as 41% THC.
Legalization has also helped open the door to products that are extracted from marijuana but look nothing like it: oily, waxy, or crystalline THC concentrates that are heated and inhaled through vaping or dabbing, which can involve a bong-like device and a blowtorch.
Today’s concentrates can be more than 90% THC. Some are billed as almost pure THC.
Reginald:
While it’s technically true that there was low THC in the 1980s – the confiscated cannabis were often left in dismal conditions. Testing wasn’t done immediately. THC degradation happens immediately and don’t be fooled – they did NOT test for THC as stringently as they claimed.
During the 1980s, THC was not their main concern. Look at the D.A.R.E PSAs and you’ll see that they didn’t talk about THC. They talked about “marijuana” or “pot” in general terms because the average consumer wasn’t too savvy about the lingo.
Of course, there was certainly a culture of breeders that were creating more potent strains via selective breeding – the fact of the matter was that law enforcement data integrity on the subject matter is very shotty to say the least.
Additionally, recent research has pointed out that a vast majority of advertised or listed cannabis potency is oftentimes over exaggerated. Realistically, most potent strains sold in dispensaries sit between about 15%-20% .
Furthermore, cannabis consumers tend to regulate their consumption. If they buy high potency cannabis, they tend to consume less of the substance. Therefore, even the mention of potency is irrelevant for the majority of consumers. However, the mainstream wouldn’t say this.
This doesn’t mean that there aren’t “problematic” consumers, but it does mean that CNN is wilfully using alarmist rhetoric to hype up the “challenges” of the industry.
CNN:
Higher concentrations pose greater hazards, according to the National Institute on Drug Abuse. “The risks of physical dependence and addiction increase with exposure to high concentrations of THC, and higher doses of THC are more likely to produce anxiety, agitation, paranoia, and psychosis,” its website said.
In 2021, 16.3 million people in the United States — 5.8% of people 12 or older — had experienced a marijuana use disorder within the past year, according to a survey published in January by the federal Department of Health and Human Services.
That was far more than the combined total found to have substance use disorders involving cocaine, heroin, methamphetamine, prescription stimulants such as Adderall, or prescription pain relievers such as fentanyl and OxyContin.
Other drugs are more dangerous than marijuana, and most of the people with a marijuana use disorder had a mild case. But about 1 in 7 — more than 2.6 million people — had a severe case, the federal survey found.
Reginald:
Firstly, cannabis has always been consumed more than the other drugs combined. Secondly, the vast majority of the “16.3 million people” were “older” than the age of 18. In fact, if you take a look at the statistics, you’ll notice that there have been a decline in use within younger generations.
While college use has risen, 18 & under has seen a slight decline.
Secondly, “Marijuana Use Disorder” is a loose term. You have to smoke like 2 joints a week to be considered “an addict” which makes anyone who is “busted with weed” essentially “addicted” according to this rhetoric.
Finally, even this article admits that the vast majority of consumers don’t have a negative experience. And their line of questioning ends there.
Why didn’t they ask, “Why did the 6 out of 7 have a good experience?” What where the differences between these people? Did it have anything to do with set and setting, history of psychotic disorders, etc?
All of these issues have practical solutions, but when you drum the “alarmist” drum, you can’t hone in on the actual important elements, you have to keep the ethereal boogieman in the center frame so that you can continue to operate with impunity.
CNN:
Uneven State Regulation
Medical use of marijuana is now legal in 40 states and the District of Columbia, and recreational or adult use is legal in 22 states plus D.C., according to MJBizDaily, a trade publication.
Early in the covid-19 pandemic, while much of America was in lockdown, marijuana dispensaries delivered. Many states declared them essential businesses.
But only two adult-use states, Vermont and Connecticut, have placed caps on THC content — 30% for cannabis flower and 60% for THC concentrates — and they exempt pre-filled vape cartridges from the caps, said Gillian Schauer from the Cannabis Regulators Association, a group of state regulators.
Some states cap the number of ounces or grams consumers are allowed to buy. However, even a little marijuana can amount to a lot of THC, said Rosalie Liccardo Pacula, a professor of health policy, economics, and law at the University of Southern California.
Some states allow only medical use of low-THC products — for instance, in Texas, substances that contain no more than 0.5% THC by weight. And some states require warning labels. In New Jersey, cannabis products composed of more than 40% THC must declare: “This is a high potency product and may increase your risk for psychosis.”
Reginald
It’s true that due to cannabis prohibition on a federal level, there is no universal regulation. However, the evidence linking high potency cannabis caps and the impact on people consuming them is limited.
Whether it’s legal or not – high potency cannabis is now a thing. Meaning, people will get it iether on the black market or the legal market.
The truth of the matter is that if you are going to “cap” how much cannabis you can buy under the guise of public safety, shouldn’t that apply to alcohol which has a higher body toll than cannabis?
Alcohol is tied to 40% of all violent crimes and domestic abuse. If there’s a candidate to “limit” in terms of potency, and availability it’s alcohol.
Yet the reason we don’t do this is due to the failed experiment of prohibition. We know that if you limit or try to prohibit certain goods – the black market steps in.
Therefore, the best approach is education. Teaching people “how” and informing them of the risks. Creating protocols for those who have “gone over the edge” and provide them with the tools to get back on track.
CNN:
The FDA has “all the power it needs to regulate state-legalized cannabis products much more effectively,” said Lindblom, the former FDA official.
At least publicly, the FDA has focused not on THC concentrates derived from cannabis or weed smoked in joints, but rather on other substances: a THC variant derived from hemp, which the federal government has legalized, and a different cannabis derivative called cannabidiol or CBD, which has been marketed as therapeutic.
“The FDA is committed to monitoring the marketplace, identifying cannabis products that pose risks, and acting, within our authorities, to protect the public,” FDA spokesperson Courtney Rhodes said.
“Many/most THC products meet the definition of marijuana, which is a controlled substance. The Drug Enforcement Administration (DEA) regulates marijuana under the Controlled Substances Act. We refer you to the Drug Enforcement Administration for questions about regulation and enforcement under the provisions of the CSA,” Rhodes wrote in an email.
The DEA, part of the Justice Department, did not respond to questions for this article.
Reginald:
That’s because, for anyone who understands how the FDA and the DEA operate, they are the gatekeepers to legalization. It’s because of this catch-22 situation that exists between the DEA and the FDA.
They have used this system for decades to stagnate research, stop any attempts of decriminalization, de-scheduling, etc.
While the FDA could regulate cannabis, I’d rather not. Since the pandemic, we have seen that the FDA is essentially an extension of big pharma. We have enough historic evidence to at the very least suggest a “heavy collaboration” between the regulatory body and those they “allegedly” regulate.
From a consumer perspective, the trust in the FDA is at an all time low. We know more about how they operate now especially due to how they handled the pandemic.
Therefore, it would be best to create a special regulatory agency apart from the FDA. Under what scheduling is alcohol and tobacco again?
CNN:
In the meantime, said Coleman, adviser to the National Cannabis Industry Association, states are left “having to become USDA + FDA + DEA all at the same time.”
And where does that leave consumers? Some, like Wendy E., a retired small-business owner in her 60s, struggle with the effects of today’s marijuana.
Wendy, who spoke on the condition that she not be fully named, started smoking marijuana in high school in the 1970s and made it part of her lifestyle for decades.
Then when her state legalized it, she bought it in dispensaries “and very quickly noticed that the potency was much higher than what I had traditionally used,” she said. “It seemed to have exponentially increased.”
In 2020, she said, the legal marijuana – much stronger than the illicit weed of her youth – left her obsessing about ways to kill herself.
Once, the self-described “earth-mother hippie” found camaraderie passing a joint with friends. Now, she attends Marijuana Anonymous meetings with others recovering from addiction to the stuff.
Reginald:
Then Wendy the earth mother should grow her own cannabis shouldn’t she? After all, she is an “earth mother”. And why would she suddenly be attending a marijuana anonymous meeting? If she’s been smoking all her life, then she had access to cannabis pre-legality.
Meaning that she has a direct link to her “OG” weed.
Something just smells way too fishy with these unprovable sob stories about weed grannies and teenagers losing their shit because of the “potent weed” when 6 in 7 have no issue with high potency weed according to the very article.
This is a tactic that was used by Randolph Hearst when he tried to smear cannabis. He invented these stories that “could be true” and since he owned the newspapers, he didn’t have to prove it to be true.
CNN, being a tool for Pfizer would most certainly advocate against cannabis for the sole reason that legalization of cannabis equals massive loss of potential revenue for pharma.
Furthermore, people often times “red pill” themselves when they smoke weed, especially, when they learn about the messed up history of cannabis prohibition.
Therefore, from what I see from this article is no different than from what Hearst and DuPont wrote about cannabis in the 1930s leading up to Reefer Madness..
The Sticky Bottom line
At the end of the day, I think that most people don’t take CNN too serious anymore. Nonetheless, they spam this into the psyche of the masses which forms social opinions. This is why I take it upon myself to eviscerate their propaganda and show a more nuanced version of the truth.
CNN AND CLICKBAIT CANNABIS HEADLINES, READ ON…
Cannabis News
US Court Rules Delta-8 THC Derived from Hemp is 100% Legal, Slamming the DEA in Embarrassing Court Case
In a groundbreaking decision, the U.S. Court of Appeals for the Ninth Circuit has ruled that Delta-8 tetrahydrocannabinol (Delta-8 THC) derived from legal hemp sources is not classified as a controlled substance under federal law, directly contradicting the Drug Enforcement Administration’s (DEA) position that all synthetically derived tetrahydrocannabinols, including Delta-8 THC, fall under Schedule I controlled substances. This landmark ruling emerged from a case brought forward by several key players in the hemp industry who challenged the DEA’s interpretation of the 2018 Farm Bill, which legalized hemp and its derivatives. The court’s decision not only rejects the DEA’s restrictive stance but also provides much-needed clarity regarding the legal status of Delta-8 THC, allowing for its continued production and sale from legally sourced hemp. This ruling is significant as it has the potential to reshape the regulatory landscape for cannabinoids, encouraging further exploration and commercialization of hemp-derived products while also highlighting the ongoing tensions between federal regulations and the rapidly evolving hemp industry.
Delta-8 THC: A Naturally Occurring Cannabinoid
Delta-8 tetrahydrocannabinol (Delta-8 THC) is a naturally occurring cannabinoid found in trace amounts in hemp and cannabis plants that shares a similar molecular structure to Delta-9 THC, the primary psychoactive compound in marijuana, but is known to produce significantly milder intoxicating effects; the 2018 Farm Bill’s legalization of hemp and its derivatives containing no more than 0.3% Delta-9 THC on a dry weight basis created a legal gray area for Delta-8 THC, which has proliferated in the form of various products derived from legal hemp sources and sold in a largely unregulated market, as they are not explicitly classified as controlled substances by the Drug Enforcement Administration (DEA) despite the agency’s stance that all synthetically derived tetrahydrocannabinols should be treated as Schedule I drugs regardless of their origin or potency, a position that has been challenged by hemp industry players arguing that Delta-8 THC from legal hemp should be exempt from the same restrictions as Delta-9 THC.
The DEA’s Stance and Industry Challenges
The Drug Enforcement Administration (DEA) has taken a firm stance that all synthetically derived tetrahydrocannabinols, including Delta-8 THC, are classified as Schedule I controlled substances under the Controlled Substances Act (CSA), regardless of their source or concentration. This position has faced considerable resistance from various stakeholders within the hemp industry, who argue that Delta-8 THC derived from legal hemp should not be subjected to the same stringent restrictions as Delta-9 THC, the primary psychoactive compound in marijuana. Proponents contend that the 2018 Farm Bill, which legalized hemp and its derivatives, should extend to include Delta-8 THC, allowing it to be treated as a legal product when sourced from hemp that contains less than 0.3% Delta-9 THC. They emphasize that while Delta-8 THC may occur naturally in small amounts in hemp, the majority of Delta-8 products on the market are produced through a chemical conversion process from CBD, which the DEA argues renders them synthetic and thus illegal. This conflict has led to ongoing legal challenges, with some courts ruling in favor of the hemp industry, asserting that Delta-8 THC should not be classified as a controlled substance when derived from legal hemp. As the debate continues, the tension between the DEA’s regulatory framework and the evolving hemp market raises critical questions about the future of cannabinoid regulation in the United States.
The Court’s Ruling and Its Implications
The U.S. Court of Appeals for the Ninth Circuit ruled that Delta-8 THC derived from legal hemp sources is not controlled substance.
-
The court found the DEA’s interpretation of the law was “arbitrary and capricious” and lacked a reasoned explanation.
-
This ruling effectively removes Delta-8 THC from the DEA’s list of controlled substances, provided it is derived from hemp containing less than 0.3% Delta-9 THC.
-
The decision provides legal protection for businesses and consumers involved in Delta-8 THC products derived from legal hemp sources.
Opportunities for the Hemp and Cannabis Industries
The recent court ruling represents a significant victory for the hemp and cannabis industries, paving the way for new possibilities in product development and research.
-
Therapeutic Potential: Delta-8 THC has been recognized for its potential therapeutic benefits, which could attract more consumers seeking alternative treatments.
-
Increased Investment: The legalization of Delta-8 THC may lead to heightened investment and innovation within the sector, encouraging the development of new products and formulations.
-
Regulatory Concerns: Despite the positive implications, the ruling also raises important concerns regarding the regulation and quality control of Delta-8 THC products, necessitating careful oversight.
-
Need for Standards: As the market for Delta-8 THC expands, there will be a pressing need for clear guidelines and standards to ensure consumer safety and product consistency, helping to build trust in these emerging products.
Broader Implications for Cannabis Legalization
The court’s ruling underscores the ongoing conflict between federal and state laws concerning the regulation of cannabis and its derivatives.
-
Increasing State Legalization: As more states advance toward the legalization of both recreational and medical marijuana, the pressure on the federal government to revise its policies and align them with shifting public opinion is likely to intensify.
-
Step Forward for Delta-8 THC: The ruling regarding Delta-8 THC may be viewed as a positive development in the broader context of cannabis legalization, yet significant challenges remain.
-
Path to Comprehensive Legalization: There is still a considerable distance to cover before achieving comprehensive federal legalization of cannabis, highlighting the complexities of navigating cannabis policy in the United States.
Conclusion
The court’s ruling underscores the ongoing conflict between federal and state laws concerning the regulation of cannabis and its derivatives. As more states advance toward the legalization of both recreational and medical marijuana, the pressure on the federal government to revise its policies and align them with shifting public opinion is likely to intensify. The ruling regarding Delta-8 THC may be viewed as a positive development in the broader context of cannabis legalization; however, significant challenges remain, and there is still a considerable distance to cover before achieving comprehensive federal legalization of cannabis, highlighting the complexities of navigating cannabis policy in the United States.
DELTA-8 THC IS LEGAL, READ MORE…
Metabolic syndrome is an umbrella term referring to several conditions that negatively impact how the body metabolizes carbohydrates, fats, and proteins.
It occurs when there are unusual, abnormal chemical processes in the body which affect otherwise healthy metabolic functions. The primary symptoms of metabolic syndrome include abdominal fat, high blood pressure, high blood sugar, high triglycerides, and low levels of LDL (good) cholesterol. These conditions all greatly increase the risk of stroke, coronary heart disease, diabetes, and other severe health issues that are difficult or near impossible to reverse.
The most telling symptom, though, is a large waist circumference – and you don’t need to take any kind of medical test to tell you this because it’s completely visible.
That’s why prevention is key when it comes to metabolic syndrome. However, the choices you make on a daily basis in your lifestyle can determine your risk for metabolic syndrome of not. We know that an unhealthy diet that is high in sugar, salt, and processed food can contribute to the symptoms of metabolic syndrome. A sedentary lifestyle, obesity, poor sleep hygiene, and exposure to chronic stress can also make the risk much worse. Smoking tobacco and alcohol are even worse – don’t even think about it.
But cannabis? That can actually help!
What Studies Say
A recent study that was published in the American Journal of Open Medicine found that young adults with a habit of consuming cannabis had a significantly lower prevalence of metabolic syndrome. For the study, investigators from the University of Miami analyzed a cohort of almost 4,000 individuals whose ages ranged from 18 to 25. They specifically zoned in on the young adults’ cannabis use.
They found that current cannabis users were 42% less likely to have metabolic syndrome. They also found that Non-Hispanic Blacks, who were consuming more weed than the other subjects, were found to be the least likely of all to have metabolic syndrome. “Current cannabis users had a lower prevalence of MetS, predominantly noted among NHB (non-Hispanic Blacks], the group with the highest prevalence of current cannabis use,” said the study’s authors. “Future prospective studies are warranted to examine the role of specific cannabinoids on MetS by race/ethnicity,” they said.
A Smaller Waist Circumference: Why You Should Pay Attention, And How Weed Can Help
Having a large waist circumference or a visibly fatty belly has been associated with numerous health conditions. Of course, this includes a heightened risk of metabolic disease. It also increases the risk of inflammation, type 2 diabetes, cardiovascular disease incidence, and cancer among others.
That is why it’s critical to pay attention to the size of your stomach. A smaller waist means you have a smaller amount of visceral fat, which is necessary for better health and an improved quality of life.
There are many steps you can take to reduce your visceral fat. These include:
-
Sticking to a low carbohydrate and low sugar diet
-
Having a diet high in good protein sources
-
Reduce consumption of trans fat and saturated fats
-
Engage in strength training and cardiovascular exercises
-
Manage stress effectively
Last but not the least: did you know that consuming cannabis has been shown to be associated with smaller waistlines and a reduced risk for obesity?
In 2020, a study out of Quebec in Canada revealed that cannabis consumption was linked to a smaller waist and reduced triglyceride levels. For this study, the investigator in Canada analyzed subjects who either never consumed marijuana in the past, used it sometime in the past but had no recent use, had some infrequent use, or consume it infrequently. They specifically measured the participants’ waist circumference and triglycerides.
They found out that the subjects who consumed certain marijuana strains for metabolic syndrome for at least 4 days per week were found to have smaller waistlines as well as less triglycerides compared to the other participants in the study.
Another study from 2015, also out of Quebec, was conducted by researchers from the Conference of Quebec University Health Centers. They analyzed cannabis consumption patterns of 786 Arctic aboriginal adults, the Inuits. The investigators also analyzed their body mass index to search for any links between cannabis use and BMI.
They found that study participants who consumed marijuana within the last year were more likely to have a lower body mass index, as well as reduced fasting insulin and better insulin resistance (using the HOMA-IR indicator) compared to those who did not.
“In this large cross-sectional adult survey with high prevalence of both substance use and obesity, cannabis use in the past year was associated with lower BMI, lower percentage fat mass, lower fasting insulin, and HOMA-IR,” said the researchers. In other words, they observed a relationship between cannabis use and BMI that led them to conclude that cannabis and cannabinoid use can help consumers reduce the likelihood of obesity and diabetes.
Meanwhile, an older study from 2013 also had similar results. Research data from The American Journal of Medicine taken from more than 4,600 patients yielded interesting findings. Almost 45% of patients never consumed marijuana in their lives, while 43% of them smoked in the past though no longer do currently. And 12% of them were regular cannabis users.
Researchers discovered that cannabis users who consumed marijuana within the past month had 16% less fasting insulin levels compared to those who never consumed weed. In addition, they even add reduced HOMA-IR levels and higher high-density lipoprotein. Furthermore, the investigators found that regular cannabis users who usually consume more calories, they also had lower BMI’s.
Conclusion
Staying fit and healthy is much more than vanity: science and medical research makes it clear that there is a strong link between obesity and body mass index, to overall health and wellness. Metabolic syndrome further emphasizes the importance of keeping one’s BMI normal, and based on these studies, that’s something cannabis can help with. Integrating responsible cannabis use into your lifestyle is one tool out of many that can help you stay healthy and reduce the risks of developing metabolic syndrome.
MORE ON METABOLIC SYNDROME AND WEED, READ ON…
‘I visited Snoop Dogg’s new pungent European cannabis café tucked down an unlikely street’
New York City-Based Dispensary Wants to Buy back Your Illegal Weed
Buying Cannabis Without Identification – GanjaVacations Jamaica
A Green Solution for Our Environment and Industries
US Court Rules Delta-8 THC Derived from Hemp is 100% Legal, Slamming the DEA in Embarrassing Court Case
What Is It, Why You Should Care, and How Cannabis Helps
7 Biggest Cannabis-Friendly Tourist Destinations
Key Information About Joint Pain And Medical Marijuana
Boomer And Gen Z Consume Marijuana For Similar Reasons
NFL picks: Joe Burrow vs. Patrick Mahomes, schematic fun in the NFC and Carolina’s QB problem lead Week 2 action
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
A new April 20 cannabis contest includes a $40,000 purse
City Of Oakland Issues RFP For Employee Training Programs
Your Go-To Source for Cannabis Logos and Designs
-
Cannabis News1 year agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders1 year agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing9 months agoDrug Testing for Marijuana – The Joint Blog
-
Marijuana Business Daily1 year agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis1 year agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
California1 year agoA new April 20 cannabis contest includes a $40,000 purse